SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The "crow with knife" meme coin, $CAW, is gaining attention, with the community actively chanting "caw caw" and emphasizing its multichain presence across Solana, BSC, CRO, and ETH. Community members highlight its fully circulated supply, deflationary mechanisms, and organic growth as key factors, with some suggesting staking opportunities are on the horizon. Chatter also mentions potential partnerships and the coin's unique branding.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin is trending as the community discusses the potential impact of the "crow with knife" meme and recent partnerships. Some traders are closely watching key resistance levels, while others express frustration with the coin's price action compared to broader market trends. There's also discussion around staking opportunities and the Cronos chain's ecosystem.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

Slap is trending as the community rallies around its unique meme-driven lifestyle and real-world partnerships, including sponsored athletes like Karolina Arm. Discussions highlight the project's strong community, consistent building, and potential for growth beyond just a meme. Some users point to the project's outperformance compared to the broader crypto market as a sign of strength.

Base Protocol (BASE) is a token whose price is pegged to the total market cap of all cryptocurrencies at a ratio of 1 : 1 trillion. BASE allows traders to speculate on the entire crypto industry with one token. If crypto market cap is $450B, BASE is $0.45. If crypto market cap is $800B, BASE is $0.80.

B3 (BASE) is trending due to its association with "crow with knife," a popular meme driving community interest and engagement. Additionally, there's discussion around new listings and potential bridging to Solana, boosting public awareness. The community is closely watching developments on the Base blockchain, with some anticipating accumulation from whales.

Kaspa was fair-launched in November 2021 with no pre-mine, zero pre-sale, and no coin allocations, and is 100 percent community-managed. Kaspa aims to be the world's global sequencer for traditional finance and decentralized crypto markets by utilizing proof-of-work and its BlockDAG consensus protocol, GHOSTDAG. Being the world's fastest proof-of-work network, Kaspa combines five properties: (1) hard money principles, (2) Bitcoin's ethos of security-first fundamentals (boasting a security threshold of fifty percent with significant market hashrate), (3) decentralization from rapid block rate mining, (4) block speeds faster than any PoW or PoS network, and (5) smart contract development through based-rollups without fragmented liquidity. Ushering in all five properties, Kaspa is on track to fulfill Satoshi Nakamoto's vision of a digital medium of exchange while also advancing global layer-one sequencing and minuscule confirmation times dominated by internet latency (cf. chapter 6 of the the paper for some initial benchmarks). The Kaspa implementation includes a lot of cool features and subprotocols including Reachability to query the DAG's topology, Block data pruning (with near-future plans for block header pruning), SPV proofs, and later subnetwork support which will make future implementation of layer 2 solutions much easier.

Kaspa

Kaspa is trending as the community eagerly anticipates the upcoming Crescendo hard fork, speculated to bring significant technological advancements. Community discussions revolve around potential price increases following the upgrade, while some express concerns about exchange listings and developer activity. Despite mixed sentiment, many remain optimistic about Kaspa's long-term potential due to its technology and fair launch.

Genius Sports Ltd. engages in the provision of scalable, technology-led products and services to the sports, sports betting, and sports media industries. It also involves in Sports League, which offers technology infrastructure for the collection, integration, and distribution of live data; Sportsbooks, which includes collection of live sports data, odds making, risk management and player marketing; and Sports Media, which provides a range of online marketing and fan engagement tools. The company was founded by Mark Adrian Locke in 2000 and is headquartered in London, United Kingdom.

Genius Sports Limited

GENI is trending as DraftKings' entry into prediction markets sparks discussions about the competitive landscape and potential impacts on data providers. The community is weighing whether this move poses a threat or opportunity for GENI, considering its existing relationships with major leagues and sportsbooks. Investors are also closely watching GENI's expansion into media and advertising through partnerships and its potential for long-term growth within the sports betting ecosystem.

GraniteShares ETF Trust - GraniteShares 2x Long AMD Daily ETF

GraniteShares 2x Long AMD Daily ETF

The GraniteShares 2x Long AMD Daily ETF ($AMDL) is trending as traders discuss AMD's potential, with some anticipating a squeeze while others express concerns about the ETF's leveraged nature and potential impact from broader market conditions. Community members are actively debating entry and exit points, with some sharing profits and others expressing frustration with the stock's performance. Bullish sentiment revolves around AMD's growth prospects, while bearish views cite macroeconomic concerns and potential manipulation.

Global X Funds - Global X Artificial Intelligence & Technology ETF

AIQ is trending as investors monitor developments in the AI sector, with discussions around the potential for both growth and bubble-like conditions. Community members are weighing the ETF's composition and exposure, particularly to international markets and specific AI-related companies. News around AI infrastructure, data centers, and talent acquisition are all impacting the broader conversation around AIQ.

Canadian Natural Resources Ltd. is an oil and natural gas production company, which engages in the exploration, development, marketing, and production of crude oil and natural gas. It operates through the following segments: Oil Sands Mining & Upgrading, Midstream & Refining, and Exploration & Production. The Oil Sands Mining & Upgrading segment produces synthetic crude oil through bitumen mining and upgrading operations. The Midstream & Refining segment focuses on maintaining pipeline operations and investment. The Exploration & Production segment consists of operations in North America, largely in Western Canada, the United Kingdom portion of the North Sea, and Côte d’Ivoire and South Africa in Africa. The company was founded on November 7, 1973 and is headquartered in Calgary, Canada.

Canadian Natural Resources Ltd.

Canadian Natural Resources is trending as investors discuss its capital allocation strategy and long-term dividend growth, with some considering it a core portfolio holding. Community members are weighing CNQ against competitors like Suncor, focusing on dividend track records and earnings outlooks. Recent news highlights CNQ's consistent dividend hikes and strong oil sands output as key factors attracting income investors.

XYO is the original and one of the largest Decentralized Physical Infrastructure Networks (DePIN), boasting over 10 million nodes and consistently leading DePIN in both scale and revenue generation. Launching its Mainnet ahead of any other DePIN, XYO specializes in collecting and validating real-world data, bridging it seamlessly to Web3 and Web2 companies across AI, geolocation, and other critical data sectors. At the core of XYO are Proof of Location and Proof of Origin technologies, enabling accurate validation of real-world data for innovative use cases such as Real-World Asset (RWA) tracking, DePIN applications, real-world gaming, and treasure hunts. Recently, XYO expanded its ecosystem by launching the XYO Layer One blockchain, purpose-built to support the intensive data demands of DePIN, RWA, AI, and similar data-driven industries. XYO employs a unique dual-token model: XYO Token: An externally traded token supporting the DePIN ecosystem, rewards, staking, and governance, enhancing overall ecosystem value and scarcity.   XL1 Token: Internal to the XYO Layer One blockchain, facilitating transactions, gas fees, and other blockchain-specific use cases. The dual-token economics are strategically designed to increase scarcity and promote sustainable growth. The XYO token is available on major exchanges, including Coinbase. The XL1 token will launch publicly later in 2025. To accelerate network adoption and growth, XYO created the popular COIN app. Beyond the XYO Foundation, the team founded the U.S.-based, for-profit entity XY Labs Inc., notable as the first U.S. crypto company qualified by the SEC for a Regulation A offering, permitting share sales to both accredited and non-accredited investors. XY Labs further stands out as one of the pioneering U.S. companies to tokenize and publicly list its shares. These tokenized shares trade as $XYLB on the tZERO ATS, positioning XY Labs prominently in the growing wave of Real-World Asset (RWA) tokenization.

XYO Network

XYO Network is trending amidst mixed sentiment, with some traders anticipating a potential pump and dump, while others express long-term optimism citing various use cases. Community members are actively debating the token's utility and the impact of staking, as well as expressing frustration with perceived lack of marketing. Some investors are eagerly awaiting news and potential catalysts to drive price action, while others are losing hope.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

All You Need to Know About Teva Pharmaceutical Industries (TEVA) Rating Upgrade to Buy

Teva Pharmaceutical Industries (TEVA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Does Teva Pharmaceutical Industries (TEVA) Have the Potential to Rally 28.12% as Wall Street Analysts Expect?

The consensus price target hints at a 28.1% upside potential for Teva Pharmaceutical Industries (TEVA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Johnson & Johnson Targets Accelerated Growth Across Segments in 2026

J&J projects faster 2026 growth in Innovative Medicine and MedTech, topping consensus estimates on both revenues and EPS.

Here's Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

JNJ Beats on Q3 Earnings, Ups Sales View, to Spin-off Orthopaedics Unit

J&J tops Q3 forecasts, lifts 2025 sales outlook and plans to spin off its struggling Orthopaedics business.

TEVA Gets FDA Nod for Uzedy Label Expansion in Bipolar I Disorder

Teva secures FDA approval for Uzedy label expansion to treat adults with bipolar I disorder.

Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know

J&J gears up for Q3 results with solid gains from Darzalex, Tremfya and MedTech, even as Stelara faces fierce biosimilar pressure.

Can Galafold Drive Amicus' Growth Through the Rest of 2025?

Galafold's steady growth, rising sales and strong patent protection position Amicus for continued growth and momentum through 2025.

Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd. - ADR

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$19.04
Prev Close	$19.02
Open	$19.07
Dividend Yield	0.00%
50-Day Moving Average	$19.07
Beta	0.79
Avg. Volume	10.79M
PE Ratio	-131.05

52-Week High	$22.80
52-Week Low	$12.47
Market Capitalization	$78.36B
EPS (Annual)	-$1.45
Price to Book	3.18
Revenue Per Employee	$456,493.49
Enterprise Value/EBITDA	N/A

TEVA
Teva- Pharmaceutical Industries Ltd. - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TEVA News

TEVATeva- Pharmaceutical Industries Ltd. - ADR